Advertisement
AnPac Bio-Medical Science... (ANPC)
AnPac Bio-Medical Science Statistics
Share Statistics
AnPac Bio-Medical Science has 6.27M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 6.27M |
| Shares Change (YoY) | 0% |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 6.04M |
| Failed to Deliver (FTD) Shares | 1.59K |
| FTD / Avg. Volume | 7.2% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is -0.6 and the forward PE ratio is null. AnPac Bio-Medical Science's PEG ratio is 0.01.
| PE Ratio | -0.6 |
| Forward PE | n/a |
| PS Ratio | 5.12 |
| Forward PS | n/a |
| PB Ratio | -4.51 |
| P/FCF Ratio | -1.09 |
| PEG Ratio | 0.01 |
Enterprise Valuation
AnPac Bio-Medical Science has an Enterprise Value (EV) of 72.16M.
| EV / Sales | 5.99 |
| EV / EBITDA | -0.92 |
| EV / EBIT | -1.31 |
| EV / FCF | -1.27 |
Financial Position
The company has a current ratio of 0.32, with a Debt / Equity ratio of -0.9.
| Current Ratio | 0.32 |
| Quick Ratio | 0.32 |
| Debt / Equity | -0.9 |
| Debt / EBITDA | -0.16 |
| Debt / FCF | -0.22 |
| Interest Coverage | -225.57 |
Financial Efficiency
Return on Equity is 757.52% and Return on Invested Capital is 6053.08%.
| Return on Equity | 757.52% |
| Return on Assets | -255.99% |
| Return on Invested Capital | 6053.08% |
| Revenue Per Employee | $135.33K |
| Profits Per Employee | $-1.16M |
| Employee Count | 89 |
| Asset Turnover | 0.3 |
| Inventory Turnover | 17.66 |
Taxes
| Income Tax | -2.13M |
| Effective Tax Rate | 2.01% |
Stock Price Statistics
The stock price has increased by -1.6% in the last 52 weeks. The beta is 1.56, so AnPac Bio-Medical Science's price volatility has been higher than the market average.
| Beta | 1.56 |
| 52-Week Price Change | -1.6% |
| 50-Day Moving Average | 5.57 |
| 200-Day Moving Average | 5.37 |
| Relative Strength Index (RSI) | 37.53 |
| Average Volume (20 Days) | 22.07K |
Income Statement
In the last 12 months, AnPac Bio-Medical Science had revenue of 12.04M and earned -103.6M in profits. Earnings per share was -54.18.
| Revenue | 12.04M |
| Gross Profit | 8.34M |
| Operating Income | -84.14M |
| Net Income | -103.6M |
| EBITDA | -78.4M |
| EBIT | -105.36M |
| Earnings Per Share (EPS) | -54.18 |
Balance Sheet
The company has 1.87M in cash and 12.31M in debt, giving a net cash position of -10.44M.
| Cash & Cash Equivalents | 1.87M |
| Total Debt | 12.31M |
| Net Cash | -10.44M |
| Retained Earnings | -577.54M |
| Total Assets | - |
| Working Capital | - |
Cash Flow
In the last 12 months, operating cash flow was -55.06M and capital expenditures -1.59M, giving a free cash flow of -56.65M.
| Operating Cash Flow | -55.06M |
| Capital Expenditures | -1.59M |
| Free Cash Flow | -56.65M |
| FCF Per Share | -29.63 |
Margins
Gross margin is 69.21%, with operating and profit margins of -698.59% and -860.16%.
| Gross Margin | 69.21% |
| Operating Margin | -698.59% |
| Pretax Margin | -877.85% |
| Profit Margin | -860.16% |
| EBITDA Margin | -650.95% |
| EBIT Margin | -698.59% |
| FCF Margin | -470.38% |
Dividends & Yields
ANPC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -167.85% |
| FCF Yield | -91.79% |
Analyst Forecast
Currently there are no analyst rating for ANPC.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 4, 2022. It was a backward split with a ratio of 1:20.
| Last Split Date | Nov 4, 2022 |
| Split Type | backward |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | null |
| Piotroski F-Score | null |